Your shopping cart is currently empty

WAY-300009-A serves as a key synthetic intermediate for the preparation of a wide range of biologically and chemically active compounds. XXX enables the development of functionalized derivatives and complex molecular scaffolds, therefore contributing to advanced research in biomedical and pharmaceutical sciences, as well as mechanistic studies in organic and medicinal chemistry.


| Description | WAY-300009-A serves as a key synthetic intermediate for the preparation of a wide range of biologically and chemically active compounds. XXX enables the development of functionalized derivatives and complex molecular scaffolds, therefore contributing to advanced research in biomedical and pharmaceutical sciences, as well as mechanistic studies in organic and medicinal chemistry. |
| In vivo | In hamster models, treatment with WAY-300009-A leads to a dramatic reduction in plasma triglycerides and LDL-cholesterol while significantly elevating HDL-cholesterol, demonstrating superior efficacy in reducing aortic atherosclerotic lesions compared to Fenofibrate. |
| Synonyms | WAY300009A |
| Molecular Weight | 465.65 |
| Formula | C29H25N2S2 |
| Cas No. | 47725-64-4 |
| Smiles | S1C=2C=CC=3C=CC=CC3C2N(C1=CC(=CC=4SC5=CC=C6C=CC=CC6=C5[N+]4C)CC)C |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.